| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 02/01/1994 | US5283321 Polypeptide compound which binds to glyco-conjugates and to artificial pertussis toxin antigen |
| 02/01/1994 | US5283320 Peptides for HTLV-2 infection diagnosis of, therapy for, vaccination against, for distinguishing between HTLV-1 and HTLV-2 infections and antibodies derived therefrom |
| 02/01/1994 | US5283191 Mareks' disease virus vaccine |
| 02/01/1994 | US5283172 Type-C rotavirus cultures and uses therefor |
| 02/01/1994 | US5283066 Method of stimulating an immune response by using a hapten |
| 02/01/1994 | US5283058 Preventing the cytolysis of lymphocyte by alternating the antigen on donor's cell |
| 01/30/1994 | CA2101348A1 Biologically active porcine somatotropin polypeptides and methods of using the same |
| 01/26/1994 | EP0580171A2 Pharmaceutical composition containing a carrier bound antitumor substance |
| 01/26/1994 | EP0579791A1 Cellular composition for the treatment of human or animal organisms |
| 01/26/1994 | EP0579758A1 Parathyroid hormone receptor and dna encoding same |
| 01/26/1994 | EP0579739A1 Interleukin-8 receptors and related molecules and methods |
| 01/26/1994 | EP0579685A1 Plasmides for the expression of filamentous haemagglutinin (fha) and hosts therefor |
| 01/26/1994 | EP0579640A1 Glial mitogenic factors, their preparation and use |
| 01/26/1994 | EP0579626A1 Method and agents for promoting wound healing |
| 01/26/1994 | EP0428573B1 Method and compositions for the treatment and prevention of septic shock |
| 01/26/1994 | EP0423301B1 Synthetic peptides of the conjugate of ubiquitine and histone h2a |
| 01/26/1994 | EP0409883B1 Monoclonal antibody to enteroviruses |
| 01/26/1994 | EP0366684B1 Ibdv vp2 epitope recognised by virus neutralising and protective monoclonal antibodies |
| 01/26/1994 | CN1081205A N-acetylglucosaminyltransferase V protein and gene |
| 01/25/1994 | US5281710 Dynemicin analogs: synthesis, methods of preparation and use |
| 01/25/1994 | US5281694 Methods and compositions for production of mycoplasmal adhesins |
| 01/25/1994 | US5281661 Contacting aqueous conductive mixture with carrier based on a polymer containing hydrophobic groups to complex factor XI |
| 01/25/1994 | US5281524 Activating cells of streptococcus mutans serotype c,e,or f, removing supernatant from culture, extracting cells with urea-containing solvent to break bonds between cells and glucosyltransferase |
| 01/25/1994 | US5281416 Swine dysentery vaccine |
| 01/25/1994 | CA1326459C Diagnostic peptides of human papilloma virus |
| 01/25/1994 | CA1326445C Cosmetic or pharmaceutical composition consisting of an aqueous dispersion of lipidic spherules |
| 01/25/1994 | CA1326444C Method for removing pertussis endoxin, pertussis toxoid and its production |
| 01/24/1994 | CA2100818A1 Pharmaceutical composition |
| 01/20/1994 | WO1994001778A1 Immunoassays for anti-hcv antibodies using antigens with conformational epitopes |
| 01/20/1994 | WO1994001573A1 Vaccines against aujeszky's disease and other animal diseases containing pseudorabies virus mutants |
| 01/20/1994 | WO1994001562A1 Bivalent living vaccines against bacterial intestinal pathogenic agents, process for preparing the same, plasmids and strains useful as base material |
| 01/20/1994 | WO1994001560A1 Allergenic proteins and peptides from japanese cedar pollen |
| 01/20/1994 | WO1994001554A1 Polypeptides, derived from endonexin 2, having hepatitis b virus receptor activity and their use in diagnostic and pharmaceutical compositions |
| 01/20/1994 | WO1994001553A1 Receptor derivates with binding sites for human rhinoviruses |
| 01/20/1994 | WO1994001552A1 Target antigens of transmission blocking antibodies for malaria parsites |
| 01/20/1994 | WO1994001547A2 A method for generation of antibodies to cell surface molecules |
| 01/20/1994 | WO1994001536A1 Cancer immunotherapy with antibodies to cancer procoagulant |
| 01/20/1994 | WO1994001533A1 Deletion mutants as vaccines for cholera |
| 01/20/1994 | WO1994001467A1 Characterization of a novel anti-p110rb monoclonal antibody |
| 01/20/1994 | WO1994001465A1 New polypeptide |
| 01/20/1994 | WO1994001458A1 Antigenic regions of tumour-liberated particles (tlp) complexes and antibodies against them |
| 01/20/1994 | WO1994001138A1 Covalent polar lipid-peptide conjugates for biological targeting |
| 01/20/1994 | WO1994001134A1 Parenteral immunization against rotavirus |
| 01/20/1994 | WO1994001133A1 Use of gm-csf as a vaccine adjuvant |
| 01/20/1994 | WO1994001132A1 VACCINE COMPRISING MIXED preS1+preS2+S AND CORE PARTICLE |
| 01/20/1994 | WO1994001131A1 Transvascular and intracellular delivery of lipidized proteins |
| 01/20/1994 | WO1994001130A1 A major histocompatibility complex antigen for use as vaccine against an immunodeficiency virus |
| 01/20/1994 | WO1994001118A1 Methods for enhancing drug delivery with modified saponins |
| 01/20/1994 | CA2140150A1 A major histocompatibility complex antigen for use as vaccine against an immunodeficiency virus |
| 01/20/1994 | CA2139756A1 Use of gm-csf as a vaccine adjuvant |
| 01/20/1994 | CA2139735A1 Polypeptides, derived from endonexin 2, having hepatitis b virus receptor activity and their use in diagnostic and pharmaceutical compositions |
| 01/20/1994 | CA2139437A1 Methods for enhancing drug delivery with modified saponins |
| 01/20/1994 | CA2138646A1 Target antigens of transmission blocking antibodies for malaria parasites |
| 01/20/1994 | CA2120954A1 Allergenic proteins and peptides from japanese cedar pollen |
| 01/20/1994 | CA2118586A1 Transvascular and intracellular delivery of lipidized proteins |
| 01/20/1994 | CA2118585A1 Characterization of a novel anti-p110rb monoclonal antibody |
| 01/20/1994 | CA2117099A1 Receptor derivatives having binding sites for human rhinoviruses |
| 01/20/1994 | CA2116971A1 Parenteral immunization against rotavirus |
| 01/19/1994 | EP0579363A1 Treatment of tropical spastic paresis with peptide T |
| 01/19/1994 | EP0578932A2 IL-2 receptor gamma chain molecule |
| 01/19/1994 | EP0578909A1 Human prohibitin and DNA coding for the same |
| 01/19/1994 | EP0578819A1 Icam-related protein |
| 01/19/1994 | EP0578818A1 Immunotherapy for recurrent hsv infections |
| 01/19/1994 | EP0578817A1 A dna sequence and encoded polypeptide useful in the diagnosis of hepatitis disease |
| 01/19/1994 | EP0578774A1 Monoclonal antibodies to stem cell factor receptors |
| 01/19/1994 | EP0578757A1 Cell surface receptors homologous to coagulation factors v and viii |
| 01/19/1994 | EP0578740A1 Method of enhancing the immunotherapeutic activity of immune cells by depletion/positive selection of cell subsets |
| 01/19/1994 | EP0578738A1 Compositions and methods for treating small cell and nonsmall cell lung cancers |
| 01/19/1994 | EP0504307B1 Method of treating septic shock |
| 01/19/1994 | CN1080957A A dna sequence and encoded peptide useful in the diagnostics of hepatites disease |
| 01/19/1994 | CN1080932A Depsispeptide derivative, preparation and application of same |
| 01/19/1994 | CN1080930A Histamine derivatives and methods for their use as immunomodulators |
| 01/19/1994 | CN1080856A Anticarcinogenic calmette-guerin injection, its preparing process and use |
| 01/19/1994 | CN1080845A Poultry color-coded inactivated vaccines |
| 01/18/1994 | US5280016 Inhibitor of smooth muscle cell proliferation at low concentration |
| 01/18/1994 | US5279965 Recombinant infectious laryngotracheitis virus |
| 01/18/1994 | US5279960 Cloned genes; eluting protective immune response when administed to avian host |
| 01/18/1994 | US5279826 Prophylactic/therapeutic composition for disseminated intravascular coagulation, chronic respiratory tract infectious disease or chronic bronchitis |
| 01/18/1994 | US5279822 Hybridoma |
| 01/18/1994 | CA1326218C Non-toxinogenic vibrio cholerae mutants |
| 01/15/1994 | CA2100377A1 Bispecific antibody |
| 01/12/1994 | EP0578356A2 Mycoplasma protein promoting metastases and antibody against it |
| 01/12/1994 | EP0578342A2 Purification and characterization of a CSVTCG-specific tumor cell adhesion receptor |
| 01/12/1994 | EP0578293A1 E-coli P-fimbrine as immunogenic carrier system against GnRH |
| 01/12/1994 | EP0577894A1 Design, construction and expression of chimeric proteins for development of vaccines and diagnostic reagents |
| 01/12/1994 | EP0577756A1 New non-anticoagulant heparin derivatives |
| 01/12/1994 | EP0577752A1 Human pf4a receptors and their use |
| 01/12/1994 | EP0577716A1 New non-anticoagulant heparin derivatives |
| 01/12/1994 | EP0577699A1 Compositions and methods to inhibit the activation of active factor xiii |
| 01/12/1994 | EP0577666A1 Polypeptides from mycobacterium paratuberculosis |
| 01/12/1994 | EP0577648A1 Novel protein polycation conjugates |
| 01/12/1994 | EP0577605A1 G protein-coupled glutamate receptors |
| 01/12/1994 | EP0463101B1 Vaccination and methods against diseases resulting from pathogenic responses by specific t cell populations |
| 01/12/1994 | EP0440700B1 Method for detection of human papillomavirus (hpv) for diagnostic purposes |
| 01/12/1994 | EP0423228B1 Immunoconjugates for cancer diagnosis and therapy |
| 01/12/1994 | EP0330661B1 Fusion proteins and particles |
| 01/12/1994 | EP0329671B1 Particulate hybrid hiv antigens |
| 01/12/1994 | EP0309566B1 Stlv-iii-related polypeptides, diagnostic systems and assay methods |
| 01/11/1994 | US5278298 Eimeria brunetti 16s rDNA probes |
| 01/11/1994 | US5278045 Method and compositions to screen compounds for enhancement of the cholinergic, dopaminergic and serotonergic function |